OptimizeRx Corp’s recent filing unveils that its Director Lang James Paul acquired Company’s shares for reported $2.44 million on Mar 14 ’25. In the deal valued at $7.60 per share,321,408 shares were bought. As a result of this transaction, Lang James Paul now holds 389,452 shares worth roughly $3.37 million.
Then, FEBBO WILLIAM J bought 20,000 shares, generating $100,220 in total proceeds. Upon buying the shares at $5.01, the CEO now owns 601,253 shares.
RBC Capital Mkts downgraded its OptimizeRx Corp [OPRX] rating to a Sector perform from a an Outperform in a research note published on January 08, 2025; the price target was decreased to $6 from $7. A number of analysts have revised their coverage, including Stephens’s analysts, who began to cover the stock in mid December with a ‘”an Equal-weight”‘ rating. JMP Securities started covering the stock on April 04, 2024. It rated OPRX as “a Mkt outperform”.
Price Performance Review of OPRX
On Monday, OptimizeRx Corp [NASDAQ:OPRX] saw its stock jump 0.23% to $8.66. Over the last five days, the stock has lost -3.78%. OptimizeRx Corp shares have risen nearly 78.19% since the year began. Nevertheless, the stocks have fallen -28.72% over the past one year. While a 52-week high of $14.13 was reached on 03/25/25, a 52-week low of $3.78 was recorded on 03/11/25. SMA at 50 days reached $6.29, while 200 days put it at $7.11.
Levels Of Support And Resistance For OPRX Stock
The 24-hour chart illustrates a support level at 8.30, which if violated will result in even more drops to 7.94. On the upside, there is a resistance level at 8.98. A further resistance level may holdings at 9.30. The Relative Strength Index (RSI) on the 14-day chart is 64.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.27, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 23.65%. Stochastics %K at 79.01% indicates the stock is a holding.
How much short interest is there in OptimizeRx Corp?
A steep rise in short interest was recorded in OptimizeRx Corp stocks on 2025-03-14, growing by 0.39 million shares to a total of 1.72 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 1.32 million shares. There was a rise of 22.84%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 03, 2024 when Barclays began covering the stock and recommended ‘”an Equal weight”‘ rating along with a $15 price target.
